Navigation Links
Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
Date:9/25/2007

treatment with standard medical care alone, with 1:1 randomization between the two groups. An adaptive design feature, increasingly common in FDA product approval trials, would permit the size of the trial to be increased after enrollment of the first 80 patients if the primary efficacy endpoint has not yet reached statistical significance but has shown a positive trend. A further and final potential extension of the trial would also be permitted to achieve statistical significance of one or more secondary endpoints of the trial relating to clinical, functional, and reimbursement advantages for SEPET(TM)-treated patients.

In parallel with the US-oriented pivotal clinical trial of the SEPET(TM) Liver Assist Device, Arbios intends to advance the product toward European market approval under the CE Mark. Arbios believes that such registration of SEPET(TM) could be accomplished significantly earlier than registration in the US, because a randomized, controlled trial is customarily not required under the European Medical Device Directives. Arbios plans to involve several leading European medical centers in the pivotal trial, so that the results of the trial will be relevant to both US and European patients and may be used to support medical payor (both private sector and government) coverage in both regions.

About Arbios' SEPET(TM) Liver Assist Device

The SEPET(TM) Liver Assist Device is a sterile, disposable cartridge containing microporous hollow fibers with proprietary permeability characteristics. When a patient's blood is passed through these fibers, blood plasma components of specific molecular weights are expressed through the micropores, thereby cleansing the blood of harmful impurities (e.g., hepatic failure toxins as well as various mediators of inflammation and inhibitors of liver regeneration). These substances would otherwise progressively accumulate in the patient's bloodstream during liver failure, causing hypotension, increasing risk of
'/>"/>

SOURCE Arbios Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
2. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
3. XTL Provides Update on Phase I Clinical Trial of XTL-2125
4. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
5. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
6. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
7. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
8. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
9. Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
10. New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
11. Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , August 27, 2014 ... Market By Products (Dental Radiology, CAD/CAM, Dental Chairs, Dental Lasers), Current ... by MarketsandMarkets, the global Dental Equipment Market is expected ... million in 2014, growing at a CAGR of ... 95 market data tables and 61 figures spread ...
(Date:8/27/2014)... 27, 2014 Reportlinker.com announces that a ... catalogue: Global Heart Valve Repair and ... About Heart Valve Repair and ... heart which control the flow of blood during ... valve diseases such as valvular stenosis, valvular insufficiency ...
(Date:8/27/2014)... 2014  Hill-Rom Holdings, Inc. (NYSE: HRC ... at the Morgan Stanley Global Healthcare Conference on September ... are invited to listen to the live discussion via ... it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded replay ... conclusion of the live event and accessible at the ...
Breaking Medicine Technology:Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4
... Reportlinker.com announces that a new market ... Depression Therapeutics - Pipeline ... http://www.reportlinker.com/p0656880/Depression-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... Forecasts to 2018 Summary ...
... LAKE, N.J., Oct. 14, 2011 Par Pharmaceutical, Inc., ... PRX ) today announced that it filed ... injunction in U.S. District Court in Washington, D.C. seeking ... information to physicians and other healthcare providers about the ...
Cached Medicine Technology:Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 2Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 3Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 4Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 5Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 6Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 7Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 8Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 9Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 10Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 2Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 3Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 4
(Date:8/27/2014)... For those who want to ... hosting products are very practical. Top10BestSEOHosting.com today announces ... are the best ASP.NET hosting suppliers of this ... a top web hosting provider for a long ... it today. Recently proclaimed one of the fastest ...
(Date:8/27/2014)... 2014 Delta, a reliable supplier of ... practical Cat D7R Dozers to its used bulldozer ... has announced that all these items are offered with ... to expand Delta’s market share in the coming September. ... the special offer; he has much confidence in the ...
(Date:8/27/2014)... UWDress.com, a popular supplier of wedding dresses and special ... of elegant bridesmaid dresses . There are more ... company's new and old customers can get a discounted ... This experienced company focuses on affordable clothes only. Its ... backless party outfits, princess wedding gowns and many others. ...
(Date:8/27/2014)... Taking its popular obstacle race to a new ... will host its largest crowd at its 3rd Annual ... YMCA Camp Thunderbird . , Hundreds of ... and teams. Within each division, runners will attempt to conquer ... for a worthy cause. All proceeds will fund scholarships ...
(Date:8/27/2014)... August 27, 2014 Reviewing the prices ... now be easier for the public when using the ... are promoted in all 50 states in the U.S. ... The different insurers that are generating the rates information ... for adults to use the programmed system without charge. ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Releases the Best ASP.NET Hosting Suppliers of This Year: Hostgator, Arvixe and FatCow 2Health News:Reliable Supplier Delta Adds New Items To Its Used Bulldozer Collection 2Health News:Elegant Bridesmaid Dresses For 2014 Now Available At UWDress.com 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2
... Services Is Anti-Competitive and Harmful to Patients and SeniorsARLINGTON, ... the American Association for Homecare and 27 regional and ... Health Reform and the leadership of the Department of ... and Medicaid Services (CMS) to review and rescind the ...
... Heart Association, with support from the Jon Holden DeHaan ... study the development and mechanisms of generating new cardiac ... centers will be conducting studies to ultimately determine how ... heart attack and heart failure patients.The grants total $6 ...
... risk of chronic obstructive pulmonary disease , , , ... smoke cigarettes and marijuana increase their risk of ... pot alone doesn,t seem to increase the risk ... Chronic obstructive pulmonary disease (COPD) is a progressive ...
... Package Health IT FundingCHICAGO, April 13 Critical ... are far less likely now to develop complications ... since the health system implemented an advanced information ... treated from 2006-2008 at 13 Resurrection ICUs, presented ...
... PHILADELPHIA, April 13 The Mobile Massage Team ( ... seated massage services for corporate wellness programs, promotional events, ... be exhibiting at the Penjerdel Employee Benefits and Compensation ... at the Philadelphia Marriott Downtown, Wednesday, April 22, 2009. ...
... 17, 10AM , INSTITUTES FOR ... Demonstration During ... April 13 Four-Star General Barry McCaffrey, the former White House Drug ... and Dr. Barry Karlin, CEO of CRC Health Group, the nation,s largest ...
Cached Medicine News:Health News:Homecare Associations Nationwide Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule 2Health News:Homecare Associations Nationwide Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule 3Health News:Homecare Associations Nationwide Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule 4Health News:Homecare Associations Nationwide Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule 5Health News:Homecare Associations Nationwide Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule 6Health News:Homecare Associations Nationwide Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule 7Health News:Three Medical Centers Awarded Funds to Study Generation of Cardiac Muscle Cells 2Health News:Pot, Cigarette Smoke Wreaks Havoc on Lungs 2Health News:Resurrection Health Uses Information Technology to Address Critical Care Crisis 2Health News:Ex-White House Drug Czar McCaffrey, U.S. Congress Drug Caucus Chair Cummings, CRC Health CEO Karlin Join Hopkins Researchers at News Conference April 17 on Breakthrough Study: Internet Video Drug Treatment as Effective as Traditional Counseling 2Health News:Ex-White House Drug Czar McCaffrey, U.S. Congress Drug Caucus Chair Cummings, CRC Health CEO Karlin Join Hopkins Researchers at News Conference April 17 on Breakthrough Study: Internet Video Drug Treatment as Effective as Traditional Counseling 3
The BARDEX I.C. Catheter represents Bard's newest technology in providing protection against NUTI....
Used for injection into urethral strictures, bladder neck contracture, and the bladder wall. Supplied sterile in peel-open packages. Intended for one-time use....
... a minimally invasive tension-free sling specifically ... resulting from urethral hypermobility (Type II) ... TF Kit is designed to accommodate ... Supplied sterile in peel-open packages. ...
... the lower ureter and inject ... submucosal tunneling. Also used to ... the ureter. The tapered tip ... of a ureteral stone. Supplied ...
Medicine Products: